Purchase Order 75N98026P00537

<p>This is a firm fixed-price purchase order awarded by the National Cancer Institute, a civilian agency, to the National Cancer Center, National Research and Development Agency in Japan. The contract is for $24,000.00 and covers laboratory testing services for the National Cancer Center. The performance period runs from the award date of May 16, 2025 through the ultimate completion date of September 15, 2025. This contract does not have a set-aside designation.</p>

<p>The National Cancer Institute issued a delivery order to Government Scientific Source Inc. on January 9, 2026, with a ceiling value of $7,343.60 under the GSA Multiple Award Schedule for Scientific Equipment and Services (FSS-66).</p> <p>Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation. Ultimate completion date is January 9, 2026.</p>

<p>The National Cancer Institute issued a delivery order to Beckman Coulter, Inc. on May 1, 2018, with a ceiling value of $15,558.00 and an ultimate completion date of April 30, 2019.</p> <p>Place of performance is Bethesda, Maryland. The order is priced firm fixed price. No set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Planon Corporation for $9,000.00 on September 1, 2025, for Planon software maintenance. Place of performance is Rockville, Maryland. The order carries a firm fixed price and an ultimate completion date of December 31, 2025. No set-aside was used.</p>

This $17,053.58 firm fixed price purchase order was awarded by the National Cancer Institute (NCI), a civilian agency, to an undisclosed prime contractor on September 11, 2024. The contract is for a service agreement with a period of performance through March 10, 2025. No set-aside designation is indicated. The contract award does not provide details about the specific products or services to be delivered, but as the NCI is the funding agency, the work is likely related to the institute's cancer...

<p>The National Cancer Institute issued a $26,697 delivery order to PHC Corporation of North America on January 3, 2019, under the GSA Multiple Award Schedule (FSS-66, Scientific Equipment and Services) for medical and scientific equipment.</p> <p>Place of performance is San Diego, CA 92121. The order has a firm fixed price and an ultimate completion date of January 2, 2020. No set-aside was used.</p>

<p>The National Cancer Institute issued a delivery order to American Type Culture Collection on August 12, 2014, with a ceiling value of $174,445.00 to support the Physical Sciences-Oncology Network Bioresource Core Facility (PBCF) by providing centralized biological specimens including cell samples.</p> <p>Place of performance is Bethesda, MD 20892. The order is firm fixed price with an ultimate completion date of August 11, 2015.</p>

<p>The National Cancer Institute issued a $5,100.20 delivery order to Illumina, Inc. on August 24, 2017, with an ultimate completion date of September 25, 2017.</p> <p>Place of performance is Bethesda, MD 20892. The order is priced on a firm fixed-price basis with no set-aside designation. The source does not specify the parent vehicle or the specific goods or services being delivered under this order.</p>

<p>The National Cancer Institute issued a $17,792.10 delivery order to Illumina, Inc. on January 13, 2020, for reagents and consumables.</p> <p>Place of performance is Bethesda, MD 20892. Ultimate completion date is February 12, 2020. The order is firm fixed price with no set-aside designation.</p>

This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian federal agency, to the National Cancer Center, a Japanese research and development agency. The contract is for $24,000.00 and requires the awardee to provide laboratory testing services, including whole-genome scans and phenotype data preparation, on 1,000 never-smoking female lung adenocarcinoma cases in Japan. The contract has an ultimate completion date of December 9, 2025. This contract...